Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2010
11/03/2010CN101874781A Lyophobic and modified glucan-modified long circulating liposome and preparation method thereof
11/03/2010CN101874777A Spray containing butenafine hydrochloride
11/03/2010CN101874776A Dry emulsion of vinpocetine and preparation method thereof
11/03/2010CN101874773A Long-acting ceftiofur hydrochloride injection and preparation method thereof
11/03/2010CN101874771A Ganciclovir-contained fructose injection liquid and preparation method thereof
11/03/2010CN101874770A Clindamycin phosphate injection and preparation method thereof
11/03/2010CN101543501B Balsatazide sodium enema liquid and preparation method thereof
11/03/2010CN101361703B Sirolimos sustained and controlled release preparation and preparation method thereof
11/03/2010CN101322747B Medicament for treating mammitis
11/03/2010CN101313989B Chinese medicinal composition for treating coronary disease, stenocardia
11/03/2010CN101313910B Preparation technique for sodium phosphocreatine freeze-dried injection
11/03/2010CN101297826B Compound Bupleurum injection for curing common cold of dog and preparation thereof
11/03/2010CN101284103B Attapulgite delousing ointment
11/03/2010CN101252923B Adhesive skin patch
11/03/2010CN101235102B Method for preparing folic acid coupling hydroxypropyl chitosan nano particles
11/03/2010CN101068529B Oily skin composition for external use for accelerating percutaneous absorption
11/03/2010CN101035509B Organo-gel formulations for therapeutic applications
11/03/2010CN101007155B Gastric-dissolved and enteric-dissolved pills of traditional Chinese medicine capable of strengthening spleen and nourishing intestine and its preparation method
11/02/2010US7825080 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
11/02/2010US7824910 Generating polyamine/polypeptide conjugate and transferring polypeptide into tissues; regeneration medicine; tissue engineering
11/02/2010US7824713 Method for treating diaper rash using superhydrated bacteriostatic topical preparation with stable acid pH
11/02/2010US7824706 synergistic efficacy; polar lipid supplement, a soluble fiber, and a nutricine such as threonine
11/02/2010US7824705 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
11/02/2010US7824700 Erodible polymers for injection
11/02/2010US7824696 Modified nucleotides for immunotherapy; induce immunology response; consisting of nucleoside methylphosphonate and 2'-O-methyl-ribonucleoside groups
11/02/2010US7824695 recombinant proteins comprise cell recognition moiety that binds alpha 2 macroglobulin receptor, and bioactive moiety (pseudomonas exotoxin), which mediates systemic effect, does not function as immunogen and does not have ADP ribosylating activity
11/02/2010US7824687 Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
11/02/2010US7824686 Vaccines with enhanced immune response and methods for their preparation
11/02/2010US7824678 Antibodies against cancer antigen TMEFF2 and uses thereof
11/02/2010CA2596977C Pyy agonists and uses thereof
11/02/2010CA2471521C Novel microsphere and method for production thereof
11/02/2010CA2467359C Electroprocessed collagen
11/02/2010CA2457097C Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
11/02/2010CA2452575C Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers
11/02/2010CA2452531C Insulating and functionalizing fine metal-containing particles with conformal ultra-thin films
11/02/2010CA2416771C 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid for treatment of cox-2 dependent disorders
11/02/2010CA2415869C Sprayable wound care compositions comprising gellan gum
11/02/2010CA2392621C Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
11/02/2010CA2383293C Anti-infective compositions for treating disordered tissue such as cold sores
11/02/2010CA2341281C Sustained-release anti-parasitic compositions comprising macrolides
11/02/2010CA2281049C Water-soluble pharmaceutical composition in an ionic complex and the use thereof
11/02/2010CA2225998C Gene preparations containing biocompatible material for sustained release in gene therapy
10/2010
10/28/2010WO2010123971A2 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010WO2010123569A2 Immunonanotherapeutics providing a th1-biased response
10/28/2010WO2010123563A2 Controlled release dispensing device
10/28/2010WO2010123443A1 Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate.
10/28/2010WO2010123440A1 Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer
10/28/2010WO2010123111A1 1-menthyl (3r)-3-hydroxybutanoate, process for producing same, and composition containing same for stimulating sense
10/28/2010WO2010123110A1 Process for producing 1-menthyl (3s)-3-hydroxybutanoate and composition for stimulating sense
10/28/2010WO2010123103A1 Adhesive patch-containing package bag and method for storing adhesive patch
10/28/2010WO2010122494A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and mometasone, and a process to make it
10/28/2010WO2010122493A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it
10/28/2010WO2010122492A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
10/28/2010WO2010122491A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it
10/28/2010WO2010122482A1 Pharmaceutical compositions for the treatment of nasal polyposis
10/28/2010WO2010122478A1 A medicinal antibacterial and steroids cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122477A1 A medicinal antifungal, antibacterial and steroid cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122476A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole and mometasone, and a process to make it
10/28/2010WO2010122475A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and mometasone, and a process to make it
10/28/2010WO2010122453A1 A medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
10/28/2010WO2010122452A1 A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122385A1 Fast-acting insulin formulation
10/28/2010WO2010122358A2 Chewable oral delivery system
10/28/2010WO2010122357A2 Delivery systems
10/28/2010WO2010122276A1 Drug delivery
10/28/2010WO2010122258A2 Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of a cosmetic or pharmaceutical agent other than water
10/28/2010WO2010122246A2 Method for forming cyclodextrin polymer and lipophilic compound emulsions, resulting emulsions, and compositions including said emulsions
10/28/2010WO2010121762A1 Paracetamol for parenteral administration
10/28/2010WO2010121559A1 Novel exendin variant and conjugate thereof
10/28/2010WO2010121503A1 Tacrolimus injection preparation
10/28/2010WO2010121455A1 A drug composition for treating tumor with polymeric micelle encapsulating antineoplastic
10/28/2010WO2010121379A1 Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
10/28/2010WO2010100477A3 Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof
10/28/2010WO2010078036A3 Biocompatible polysaccharide-based hydrogels
10/28/2010WO2010068754A3 Methods and compositions for delivery of medicaments to the lungs
10/28/2010WO2009143175A3 Sensory-specific local anesthesia and prolonged duration local anesthesia
10/28/2010US20100273896 Method for producing products with water clusters
10/28/2010US20100273882 Use of adapalene gel or cream
10/28/2010US20100273873 Direct compressible dextrose
10/28/2010US20100273866 Diagnosis and treatment of cancer: i
10/28/2010US20100273843 Heterocyclic self-immolative linkers and conjugates
10/28/2010US20100273822 Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins
10/28/2010US20100273760 Topical Pharmaceutical Formulations And Methods Of Treatment
10/28/2010US20100273728 Formulations For The Oral Administration of Therapeutic Agents and Related Methods
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010US20100272831 Process for manufacturing nanocomposite materials for multisectoral applications
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
10/28/2010US20100272808 Shell-and-Core Dosage Form Approaching Zero-Order Drug Release
10/28/2010US20100272761 Synthesis of lipoamide-grafted high molecular compound and method therefor
10/28/2010US20100272693 Bone scaffolds, injectable bone repair materials and methods for bone repair
10/28/2010US20100272675 Method of administering conjugates
10/28/2010US20100272661 Process for the preparation of inverse latex of acrylamide-based polymers and composition comprising said latex
10/28/2010US20100272649 Bioactive Bone Cement and Method for Its Production
10/28/2010DE4124468B4 Verfahren zur Gewinnung eines Polylactids in gereinigtem Zustand sowie ein Verfahren zur Herstellung einer pharmazeutischen Zusammensetzung mit den gereinigten Polylactiden A process for obtaining a polylactide in a purified state and a process for preparing a pharmaceutical composition comprising the purified polylactides
10/28/2010CA2759807A1 Controlled release dispensing device
10/28/2010CA2759727A1 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010CA2759541A1 Delivery systems
10/28/2010CA2759332A1 Immunonanotherapeutics providing a th1-biased response
10/28/2010CA2759129A1 Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
10/28/2010CA2759060A1 A drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 1712